Is RORγ a therapeutic target for treating Mycobacterium tuberculosis infections?
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference58 articles.
1. Challenges and opportunities in developing novel drugs for TB;Kaneko;Future Med Chem,2011
2. The challenge of new drug discovery for tuberculosis;Koul;Nature,2011
3. Tuberculosis: what we don’t know can, and does, hurt us;Russell;Science,2010
4. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century;Burman;Clin Inf Dis,2010
5. Resistant TB: newer drugs and community approach;Gothi;Recent Pat Antiinfect Drug Discov,2011
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fenofibrate Facilitates Post-Active Tuberculosis Infection in Macrophages and is Associated with Higher Mortality in Patients under Long-Term Treatment;Journal of Clinical Medicine;2020-01-25
2. Interleukin-17A as a Biomarker for Bovine Tuberculosis;Clinical and Vaccine Immunology;2016-02
3. Normalization of the levels of inflammatory molecules in Mycobacterium smegmatis-infected U937 cells by fibrate pretreatment;Biological Research;2014-09-15
4. Relevance of bovine tuberculosis research to the understanding of human disease: Historical perspectives, approaches, and immunologic mechanisms;Veterinary Immunology and Immunopathology;2014-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3